![](/img/cover-not-exists.png)
PDB27 COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR TYPE 2 DIABETES PATIENTS IN CHINA
M Lynch, H Scheijbeler, R Kotchie, S Nielsen, J White, WJ ValentineVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64975-3
File:
PDF, 75 KB
english, 2007